JP2008530225A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008530225A5 JP2008530225A5 JP2007556275A JP2007556275A JP2008530225A5 JP 2008530225 A5 JP2008530225 A5 JP 2008530225A5 JP 2007556275 A JP2007556275 A JP 2007556275A JP 2007556275 A JP2007556275 A JP 2007556275A JP 2008530225 A5 JP2008530225 A5 JP 2008530225A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- compound according
- powder
- ray diffraction
- diffraction pattern
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65367705P | 2005-02-17 | 2005-02-17 | |
| PCT/US2006/005399 WO2006088988A1 (en) | 2005-02-17 | 2006-02-16 | Crystalline form of an indazole-carboxamide compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008530225A JP2008530225A (ja) | 2008-08-07 |
| JP2008530225A5 true JP2008530225A5 (https=) | 2009-03-26 |
Family
ID=36424659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007556275A Pending JP2008530225A (ja) | 2005-02-17 | 2006-02-16 | インダゾール−カルボキサミド化合物の結晶型 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20060183901A1 (https=) |
| EP (1) | EP1848716A1 (https=) |
| JP (1) | JP2008530225A (https=) |
| TW (1) | TW200640921A (https=) |
| WO (1) | WO2006088988A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI377206B (en) | 2005-04-06 | 2012-11-21 | Theravance Inc | Crystalline form of a quinolinone-carboxamide compound |
| GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
| CN101384588B (zh) * | 2006-02-16 | 2011-08-31 | 施万制药 | 制备5-ht4受体激动剂化合物的中间体的方法 |
| CA2734900A1 (en) * | 2008-08-19 | 2010-02-25 | Shu-Ping Chen | Polymorphic form of granisetron hydrochloride and methods of making the same |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| WO2011092290A1 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
| AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
| EP2531490B1 (en) | 2010-02-02 | 2014-10-15 | Novartis AG | Cyclohexyl amide derivatives as crf receptor antagonists |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4937247A (en) * | 1985-04-27 | 1990-06-26 | Beecham Group P.L.C. | 1-acyl indazoles |
| IT1226389B (it) * | 1988-07-12 | 1991-01-15 | Angeli Inst Spa | Nuovi derivati ammidinici e guanidinici |
| JP3829879B2 (ja) * | 1994-05-18 | 2006-10-04 | 大正製薬株式会社 | キノリンカルボン酸誘導体 |
| US5654320A (en) * | 1995-03-16 | 1997-08-05 | Eli Lilly And Company | Indazolecarboxamides |
| IT1291569B1 (it) * | 1997-04-15 | 1999-01-11 | Angelini Ricerche Spa | Indazolammidi come agenti serotoninergici |
| US6069152A (en) * | 1997-10-07 | 2000-05-30 | Eli Lilly And Company | 5-HT4 agonists and antagonists |
| TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
| CA2588037A1 (en) * | 2004-12-22 | 2006-06-29 | Theravance, Inc. | Indazole-carboxamide compounds |
-
2006
- 2006-02-16 WO PCT/US2006/005399 patent/WO2006088988A1/en not_active Ceased
- 2006-02-16 TW TW095105173A patent/TW200640921A/zh unknown
- 2006-02-16 EP EP06735182A patent/EP1848716A1/en not_active Withdrawn
- 2006-02-16 JP JP2007556275A patent/JP2008530225A/ja active Pending
- 2006-02-16 US US11/355,323 patent/US20060183901A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008535848A5 (https=) | ||
| JP5546717B2 (ja) | アリピプラゾール結晶質形態を調製する方法 | |
| JP3800220B2 (ja) | 酢酸アニリド誘導体のα型又はβ型結晶 | |
| JP2005533860A5 (https=) | ||
| JP2009506014A5 (https=) | ||
| JP6008937B2 (ja) | １−（３−シアノ−１−イソプロピル−インドール−５−イル）ピラゾール−４−カルボン酸の結晶形とその製造方法 | |
| JP2020059759A5 (https=) | ||
| JP2017527578A5 (https=) | ||
| JPWO2003097042A1 (ja) | Ｐｇｄ２受容体拮抗剤 | |
| JP2007532546A5 (https=) | ||
| JP2008513358A5 (https=) | ||
| JP2008530225A5 (https=) | ||
| JP2010132680A (ja) | Ｐｇｄ２受容体拮抗作用を有する化合物 | |
| JP2020517611A5 (https=) | ||
| JP2008525466A5 (https=) | ||
| JP2012533550A5 (https=) | ||
| TWI706949B (zh) | (３-胺基-環氧丙-３-基甲基)-[２-(５,５-二氧-５,６,７,９-四氫-５入*６*-硫-８-氮雜-苯并環庚烯-８-基)-６-甲基-喹唑啉-４-基]-胺之新穎晶形 | |
| JP2008518975A5 (https=) | ||
| JP2019014762A (ja) | ニロチニブ塩酸塩の多形形態 | |
| JP2008511569A (ja) | 注意欠如活動過多障害の治療方法 | |
| JP2007538084A5 (https=) | ||
| EA023293B1 (ru) | ЛИГАНДЫ НЕЙРОНАЛЬНОГО НИКОТИНОВОГО АЦЕТИЛХОЛИНОВОГО РЕЦЕПТОРА αβ | |
| JP2009512624A5 (https=) | ||
| JP2008518965A5 (https=) | ||
| JP2008515907A5 (https=) |